Chemours Co. logo

Chemours Co. (CC)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
22. 61
-0.64
-2.75%
After Hours
$
23. 41
+0.8 +3.54%
3.42B Market Cap
- P/E Ratio
1% Div Yield
1,508,991 Volume
- Eps
$ 23.25
Previous Close
Add Transaction
Day Range
22.6 23.37
Year Range
9.94 28.67
Want to track CC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Trump's Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30

Trump's Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30

American manufacturing is having a moment. Reshoring incentives, the AIM Act refrigerant transition, EV plant buildouts, and aerospace demand are pushing capital back into U.S.

247wallst | 2 weeks ago
Chemours Q1 Earnings Call Highlights

Chemours Q1 Earnings Call Highlights

Chemours NYSE: CC said it opened 2026 with first-quarter results that were “well above earnings expectations,” driven by strong execution in its Thermal & Specialized Solutions and Titanium Technologies segments, while Advanced Performance Materials continued to recover from an outage at the company's Washington Works facility.

Marketbeat | 3 weeks ago
Chemours' Q1 Earnings Surpass Estimates, Revenues Miss

Chemours' Q1 Earnings Surpass Estimates, Revenues Miss

CC posted a wider Q1 loss as lower volumes hurt key segments, but pricing gains and upbeat Q2 sales guidance supported EBITDA.

Zacks | 3 weeks ago
The Chemours Company (CC) Q1 2026 Earnings Call Transcript

The Chemours Company (CC) Q1 2026 Earnings Call Transcript

The Chemours Company (CC) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago
Chemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say

Chemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 4 weeks ago
Why I Just Became Even More Bullish On The Canton Network

Why I Just Became Even More Bullish On The Canton Network

The article analyzes the Canton Network and its CIP-0105 update, which incentivizes Super Validators to lock rewards, aligning interests with long-term network success. CIP-0105 could result in 20–32% of Canton Coin supply being locked over the long run, reducing circulating supply and disincentivizing opportunistic selling. Major financial institutions like Nasdaq, DTCC, and others serve as Super Validators, signaling strong institutional adoption and potential for network effects.

Seekingalpha | 2 months ago
Chemours Sees Unusually Large Options Volume (NYSE:CC)

Chemours Sees Unusually Large Options Volume (NYSE:CC)

The Chemours Company (NYSE: CC - Get Free Report) saw some unusual options trading activity on Friday. Stock investors purchased 10,642 call options on the company. This is an increase of 182% compared to the typical volume of 3,771 call options. Chemours Stock Performance Shares of CC stock opened at $17.60 on Friday. Chemours has a

Defenseworld | 2 months ago
Chemours Upsizes and Prices $700 Million Senior Notes Offering

Chemours Upsizes and Prices $700 Million Senior Notes Offering

CC prices $700M of 7.875% senior notes due 2034, upsizing the deal to refinance 2027 and 2028 debt and reshape its debt profile.

Zacks | 3 months ago
Chemours: No Rush To Buy The Dip Given Non-AI Pressures (Downgrade)

Chemours: No Rush To Buy The Dip Given Non-AI Pressures (Downgrade)

Chemours Company is downgraded to "Hold" after a sharp rally, with shares now fairly valued around $18. CC's TSS segment benefits from Opteon adoption and future data center demand, but other units face ongoing macro headwinds. Leverage remains elevated at 4.7x; asset sales and cash flow should reduce leverage to 4x by year-end, but further progress will be slow.

Seekingalpha | 3 months ago
Chemours' Q4 Earnings Surpass Estimates, Revenues In Line

Chemours' Q4 Earnings Surpass Estimates, Revenues In Line

CC posts a wider y/y loss in Q4 as sales dip 2%, but the bottom line beats estimates and Thermal & Specialized Solutions surges on strong refrigerant pricing.

Zacks | 3 months ago
Compared to Estimates, Chemours (CC) Q4 Earnings: A Look at Key Metrics

Compared to Estimates, Chemours (CC) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 3 months ago
Chemours (CC) Beats Q4 Earnings Estimates

Chemours (CC) Beats Q4 Earnings Estimates

Chemours (CC) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of breakeven. This compares to earnings of $0.11 per share a year ago.

Zacks | 3 months ago
Loading...
Load More